Exchange: NASDAQ·Updated 04:27 PM EST

ADMA News

News
all
press releases
Insider Selling: ADMA Biologics (NASDAQ:ADMA) Director Sells $139,200.00 in Stock
ADMA Biologics Inc (NASDAQ:ADMA - Get Free Report) Director Lawrence Guiheen sold 10,000 shares of the stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $13.92, for a total transaction of $139,200.00. Following the sale, the director directly...
MarketBeat
Insider Selling: ADMA Biologics (NASDAQ:ADMA) Director Sells $139,200.00 in Stock
ADMA Biologics Inc (NASDAQ:ADMA - Get Free Report) Director Lawrence Guiheen sold 10,000 shares of the stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $13.92, for a total transaction of $139,200.00. Following the sale, the director directly...
MarketBeat
More News
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
ADMA Biologics gains 20.9% after strong Q3 results, as surging Asceniv sales and a raised 2026 profit outlook offset Bivigam weakness and competitive pressures.
Zacks
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Zacks
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Zacks
Gainers Lakewood-Amedex (NASDAQ:LABT) shares moved upwards by 237.6% to $0.65 during Thursday's regular session. ADMA Biologics (NASDAQ:ADMA) stock increased by 25.62% to $13.16. The market value of theirread more...
Benzinga
Adma Biologics (ADMA) delivered earnings and revenue surprises of +15.79% and +0.93%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
In the closing of the recent trading day, Adma Biologics (ADMA) stood at $11.41, denoting a -2.89% move from the preceding trading day.
Zacks
According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Zacks

Advertisement|Remove ads.